INCYTE CORPORATION Inventory, Finished Goods, Net of Reserves
INCYTE CORPORATION (INCY) had Inventory, Finished Goods, Net of Reserves of $58.87 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-04-28
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $58.87M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $71.75M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $64.87M.
- 2025-06-30: Inventory, Finished Goods, Net of Reserves $56.82M.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2026-03-31 | $58.87M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $71.75M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $64.87M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $56.82M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $47.50M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $48.43M 10-K · filed 2026-02-10 |
| 2024-09-30 | $47.41M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $46.69M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $49.47M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $36.86M 10-K · filed 2025-02-10 |
| 2023-09-30 | $36.91M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $22.38M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $34.29M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $34.63M 10-K · filed 2024-02-13 |
| 2022-09-30 | $33.38M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $35.44M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $18.86M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $15.77M 10-K · filed 2023-02-07 |
| 2021-09-30 | $14.93M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $13.68M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $12.06M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $13.46M 10-K · filed 2022-02-08 |
| 2020-09-30 | $14.69M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $13.99M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $9.71M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $6.60M 10-K · filed 2021-02-09 |
| 2019-09-30 | $6.13M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $4.00M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $5.09M 10-Q · filed 2019-04-30 |
| 2018-12-31 | $6.44M 10-K · filed 2020-02-13 |
| 2018-09-30 | $5.99M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $5.87M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $4.63M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $4.77M 10-K · filed 2019-02-14 |
| 2017-09-30 | $3.26M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $2.93M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $3.96M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $4.11M 10-K · filed 2018-02-15 |
| 2016-09-30 | $4.08M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $6.12M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.31M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $1.78M 10-K · filed 2017-02-14 |
| 2015-09-30 | $2.43M 10-Q · filed 2015-11-03 |
| 2015-06-30 | $1.90M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $2.41M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $358.00K 10-K · filed 2016-02-12 |
| 2014-09-30 | $402.00K 10-Q · filed 2014-10-30 |
| 2014-06-30 | $269.00K 10-Q · filed 2014-07-31 |
| 2014-03-31 | $347.00K 10-Q · filed 2014-05-01 |
| 2013-12-31 | $406.00K 10-K · filed 2015-02-17 |
| 2013-09-30 | $359.00K 10-Q · filed 2013-10-31 |
| 2013-06-30 | $133.00K 10-Q · filed 2013-08-01 |
| 2013-03-31 | $189.00K 10-Q · filed 2013-05-02 |
| 2012-12-31 | $278.00K 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |